Genovis AB engages in the research and development of enzyme products. Its product portfolio includes SmartEnzymes, which offers to pharmaceutical and medical device industries tools that facilitate the development of new treatment methods and diagnostics. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Kävlinge, Sweden.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
36
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Genovis AB market cap is $480.74M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Genovis AB 52 week high is $7.34 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Genovis AB 52 week low is $7.34 as of November 18, 2026.
Genovis AB stock price today is $7.34.
Genovis AB stock price yesterday was $7.34.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Genovis AB's P/E ratio is 108.47.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Genovis AB P/B ratio is 40.174.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Genovis AB 50-day moving average is $7.34.